Tissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration status

Nanomedicine

Volumn 7, Issue 2, 2012, Pages 199-209

  Keene, Athena M ^a   Peters, David ^a   Rouse, Rodney ^a   Stewart, Sharron ^a   Rosen, Elliot T ^a   Tyner, Katherine M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

agglomeration; aggregation; biodistribution; gold nanoparticles

Indexed keywords

GOLD NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD CHEMISTRY; CELL AGGREGATION; CELL STRUCTURE; FECES; FEMALE; HEART; HISTOPATHOLOGY; IN VIVO STUDY; INTESTINE; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; OVARY; PANCREAS; PRIORITY JOURNAL; STOMACH; THYMUS; URINE; UTERINE TUBE; UTERUS;

ANIMALS; BLOOD CHEMICAL ANALYSIS; DIFFUSION; FEMALE; GOLD; MICE; MICE, INBRED BALB C; NANOPARTICLES; ORGAN SPECIFICITY; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 84857614060     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.125     Document Type: Article

References (32)

1. Keene AM, Tyner KM. Analytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregates. J. Nanopart. Res. 13, 3465-3481 (2011).
2. Cho K, Lee Y, Lew CH, et al. Selective aggregation mechanism of unmodified gold nanoparticles in detection of single nucleotide polymorphism. J. Phys. Chem. C. 112, 8629-8633 (2008).
3. Jans X, Liu X, Austin L, Maes G, Huo Q. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. Anal. Chem. 81, 9425-9432 (2009).
4. Oh E, Susumu K, Goswami R, Mattoussi H. One-phase synthesis of water-soluble gold nanoparticles with control over size and surface functionalities. Langmuir 26, 7604-7613 (2010).
5. Dash P, Scott RWJ. 1-methylimidazole stabilization of gold nanoparticles in imidazolium ionic liquids. Chem. Comm. (7), 812-814 (2009).
6. Sylvestre JP, Kabashin AV, Sacher E, Meunier M, Luong JHT. Stabilization and size control of gold nanoparticles during laser ablation. J. Am. Chem. Soc. 126, 7176-7177 (2004).
7. Rahme K, Vicendo P, Ayela C, et al. A simple protocol to stabilize gold nanoparticles using amphilipic block copolymers: stability studies and viable cellular uptake. Chemistry 15, 11151-11159 (2009).
8. Tyner KM, Wokovich AM, Godar DE, Doub WE, Nadrieh N. The state of nano-sized titanium dioxide (TiO2) may affect sunscreen performance. Int. J. Cosmetic Sci. 33, 234-244 (2011).
9. Ispas C, Andreescu D, Patel A, Goia DV, Andreescu S, Wallace KN. Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ. Sci. Technol. 43, 6349-6356 (2009).
10. Kim SC, Chen DR, Qi C, et al. A nanoparticle dispersion method for in vitro and in vivo nanotoxicity. Nanotoxicology 4, 42-51 (2010).
11. Mutlu GM, Budinger GRS, Green AA, et al. Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett. 10, 1664-1670 (2010).
12. Jarvie HP, Al-Obaidi J, King SM, et al. Fate of silica nanoparticles in simulated primary wastewater treatment. Environ. Sci. Technol. 43, 8622-8628 (2009).
13. Lovern SB, Klaper R. Daphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticles. Environ. Toxicol. Chem. 25, 1132-1137 (2006).
14. Zolnik BS, Sadrieh N. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Adv. Drug Deliv. Rev. 61, 422-427 (2009).
15. Service RF. Nanoparticle trojan horses gallop from the lab into the clinic. Science 330, 314-315 (2010).
16. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after administration: effect of particle size. Coll. Surf. B. 66, 274-280 (2008).
17. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919 (2008).
18. Kobayashi H, Brechbiel MW. Dendrimer-based macromolecular MRI contrast agents: characteristics and applications. Mol. Imaging 2, 1-10 (2003).
19. Riviere JE. Pharmacokinetics of nanomaterials: An overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 1, 26-34 (2009).
20. National Research Council. Guide for the Care and Use of Laboratory Animals. National Academy Press, DC, USA (1996).
21. Daniel MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293-346 (2004).
22. Lacerda SHDP, Park JJ, Meuse C, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4, 365-379 (2010).
23. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Exp. Opin. Drug Deliv. 7, 753-763 (2010).
24. Weitz DA, Huang JS, Lin MY, Sung J. Limits of fractal dimensions for irreversible kinetic aggregation of gold colloids. Phys. Rev. Lett. 54, 1416-1419 (1985).
25. Zhang, G, Yang Z, Lu W, et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30, 1928-1936 (2009).
26. Figueiredo AMG, Enzweiler J, Sarkis JES, Jorge APS, Shibuya EK. NAA and UV laser ablation ICP-MS for platinum group elements and gold determination in NiS fire assay buttons: A comparison between two methods. J. Radioanal. Nucl. Chem. 244, 623-625 (2000).
27. Suchow MA, Danneman P, Brayton C. The Laboratory Mouse. CRC Press, FL, USA, 124-125 (2001).
28. Illum L, Davis SS, Wilson CG, Thomas NW, Frier M, Hardy JG. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape. Int. J. Pharm. 12, 135-146 (1982).
29. Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-1170 (2007).
30. Ogawara K, Yoshida M, Higaki K, et al. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. J. Control. Rel. 59, 15-22 (1999).
31. Popielarski SR, Hu-Lieskovan S, French SW, Triche TJ, Davis ME. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. Bioconjugate Chem. 16, 1071-1080 (2005).
32. Choi HS, Ashitate Y, Lee JH, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 28, 1300-1303 (2010).